Total Visits

Views
The Proteasome Inhibitor Bortezomib Sensitizes AML with Myelomonocytic Differentiation to TRAIL Mediated Apoptosis717

Total Visits Per Month

June 2016July 2016August 2016September 2016October 2016November 2016December 2016
The Proteasome Inhibitor Bortezomib Sensitizes AML with Myelomonocytic Differentiation to TRAIL Mediated Apoptosis1619221

File Visits

Views
cancers-03-01329.pdf668
license.txt63
sword-2012-02-16.original2

Top country views

Views
United States339
China85
Ireland84
Germany26
Russia16
Japan14
Netherlands14
United Kingdom11
France8
Belarus7

Top cities views

Views
Cleveland66
Mountain View56
Woodbridge42
Oranmore39
Sunnyvale35
Gaillimh34
Beijing30
Seattle11
Kiez8
Leipzig8